Get started
Author

Maibritt Nørgaard

Observed names: Maibritt Norgaard, Nørgaard, Maibritt
ORCID: 0000-0002-9626-6510
Observed ORCID: 0000-0002-9626-6510
OpenAlex ID: A5059264635
Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors
2021 · Line B Andersen, Maibritt Nørgaard, et al. · The Journal of Pathology · 77
FRMD6 has tumor suppressor functions in prostate cancer
2020 · Jakob Haldrup, Siri H. Strand, et al. · Oncogene · 42
Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer
2023 · Maibritt Nørgaard, Marianne T Bjerre, et al. · Clinical Chemistry · 41
PDF
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
2019 · Marianne T. Bjerre, Siri H. Strand, et al. · International Journal of Molecular Sciences · 40
PDF
Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
2020 · Marianne Trier Bjerre, Maibritt Nørgaard, et al. · Cells · 33
PDF
Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
2017 · Maibritt Nørgaard, Christa Haldrup, et al. · International Journal of Molecular Sciences · 27
PDF
Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization
2022 · Gabriel Renaud, Maibritt Nørgaard, et al. · eLife · 22
Epigenetic silencing of MEIS2 in prostate cancer recurrence
2019 · Maibritt Nørgaard, Christa Haldrup, et al. · Clinical Epigenetics · 18
PDF
Exploring the tumor genomic landscape of aggressive prostate cancer by whole‐genome sequencing of tissue or liquid biopsies
2024 · Simone Weiss, Philippe Lamy, et al. · International Journal of Cancer · 6
PDF
Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer
2025 · Maibritt Nørgaard, Maria Rusan, et al. · Journal of Experimental & Clinical Cancer Research · 4
PDF
Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer
2026 · Karoline Kondrup, Laura Iisager, et al. · British Journal of Cancer · 1
PDF
Author response: Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization
2022 · Gabriel Renaud, Maibritt Nørgaard, et al. · 1
Abstract 1180: Integrating methylation-based circulating tumor DNA analysis with PSMA-PET/CT primary staging for enhanced risk stratification in de novo metastatic prostate cancer.
2026 · Karoline Kondrup, Mads Ryø Jochumsen, et al. · Cancer Research
Abstract 3409: Whole genome sequencing of liquid tumor biopsies (ctDNA) from men with metastatic castration resistant prostate cancer
2022 · Simone Weiss, Philippe Lamy, et al. · Cancer Research
Prostate Cancer Tumor Evolution and Identification of Prognostic and Predictive Biomarkers
2018 · Maibritt Nørgaard, Christa Haldrup, et al.
Works count: 32
Citation count: 312
H-index: 8
I10-index: 8
Year
Topic
Type